Arch Clinical Trials, LLC
Saint Louis, Missouri, United States
Medical laboratory in the Lemay, Missouri
1400 Lemay Ferry Rd, St. Louis, MO 63125
About Arch Clinical Trials, LLC
"We specialize in mental health research. Your participation in a voluntary clinical trial is needed and appreciated. With your help, together, we can make a difference! Your participation helps to develop new treatments that improve and advance medical care for future generations. If you're interested in participating in an Alzheimer's Disease, Schizophrenia, Bipolar or Borderline Personality Disorder research trial call us today."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Arch Clinical Trials, LLC
During the past decade, Arch Clinical Trials, LLC conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 9 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease
2012-10-05
2019-07-31
Terminated
197
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
2014-04-22
2016-12-22
Completed
258
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
2016-03-31
2018-01-18
Completed
493
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics
2016-11-30
2019-12-12
Completed
214
Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD
2018-05-11
2019-09-30
Completed
62
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
2017-09-19
2019-01-22
Completed
333
A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.
2017-10-24
2019-07-31
Completed
381
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
2017-12-07
2021-03-31
Terminated
264
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Arch Clinical Trials, LLC" #1 sponsor was "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials, followed by "Karuna Therapeutics" with 3 trials
sponsored, "Sunovion" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Allergan"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Arch Clinical Trials, LLC"
#1 collaborator was "H. Lundbeck A/S" with 2 trials as a collaborator, "Cognitive Research Corporation" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Arch Clinical Trials, LLC
According to Clinical.Site data, the most researched conditions in "Arch Clinical Trials, LLC" are
"Schizophrenia" (12 trials), "Bipolar I Disorder" (2 trials), "Depressive Disorder, Major" (2 trials), "Acute Mania" (1 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Arch Clinical Trials, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Arch Clinical Trials, LLC
Most popular intervention types in "Arch Clinical Trials, LLC" are "Drug" (19 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Brexpiprazole" (3 trials), "Xanomeline and Trospium Chloride Capsules" (3 trials), "SEP-363856 75mg" (2 trials) and "ASP4345" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Arch Clinical Trials, LLC
The vast majority of trials in "Arch Clinical Trials, LLC" are
19 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Arch Clinical Trials, LLC
Currently, there are NaN active trials in "Arch Clinical Trials, LLC".
undefined are not yet recruiting,
5 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Arch Clinical Trials, LLC,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Arch Clinical Trials, LLC, 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".